Pharmaceutical

ESCMID 2024: Advances in drug resistance testing

Techniques such as rapid nanomotion-based susceptibility testing, and MALDI-TOF-MS could be used to identify resistance mechanisms of several deadly organisms.

May 5, 2024 - 00:00
ESCMID 2024: Advances in drug resistance testing
Techniques such as rapid nanomotion-based susceptibility testing, and MALDI-TOF-MS could be used to identify resistance mechanisms of several deadly organisms.
Read the original article

Tags:

Previous Article

Lexicon plans another bid for Zynquista in type 1 diabetes

Next Article

NHS to provide Pfizer’s Voxelotor to treat sickle cell disease

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

The four biotech stories you need to read this morning

The four biotech stories you need to read this morning

Jan 16, 2024

STAT+: Mirum’s Chenodal succeeds in late-stage trial for rare metabolic disorder

STAT+: Mirum’s Chenodal succeeds in late-stage trial fo...

Oct 2, 2023

No more cookies: How healthcare companies can gain trust for data consent

No more cookies: How healthcare companies can gain trus...

Sep 15, 2023